For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on February 24th, 2025 | 07:10 CET
BUY RECOMMENDATION for Hensoldt! TUI with 60% upside potential! Resource Gem Nova Pacific Metals!
Analysts have recently declared a supercycle for the European defense industry. Regardless of who will govern Germany in the future, billions will flow into armaments. One profiteer is Hensoldt. Despite the strong performance, analysts recommend buying the stock. Nova Pacific Metals also appears attractive. The explorer is sitting on a treasure trove of raw materials and has just expanded its territory. The hidden gem not only benefits from the gold supercycle but also from a wide range of raw materials. Positive news flow should drive the share this year. And what is TUI doing? Is the tourism supercycle really over? "No," says a board member and buys shares. Experts see a 60% price opportunity!
Read
Commented by Fabian Lorenz on February 20th, 2025 | 07:30 CET
Multiplier potential with AI newcomer NetraMark! Palantir and BioNTech in one share!
"Game changer!" "Quantum leap!" "Revolution!" Experts use numerous superlatives to describe the possibilities of Artificial Intelligence (AI) in medicine. What is certain is that AI offers tremendous potential to develop new medications faster and more cost-effectively. Pharmaceutical companies can save billions, and patients can be cured more quickly. The market for AI in medicine is expected to see significant double-digit growth rates in the coming years. NetraMark Holdings aims to profit from this megatrend. The AI specialist is on the verge of a breakthrough and is starting 2025 with a software update, an important partnership, and reinforcements in top management. The share price has jumped but remains a hidden gem and is anything but expensive. There is significant upside potential!
Read
Commented by Fabian Lorenz on February 20th, 2025 | 07:10 CET
Renk in a SUPERCYCLE! Elon Musk wants gold! USD 3,500 an ounce? Barrick off to a good start, but Globex Mining does better!
Will Renk shares soon reach an all-time high? The EUR 30 mark was broken yesterday. According to analysts, the defense stock will likely continue its FOMO rally. Like Hensoldt and Rheinmetall, the transmission manufacturer is in the supercycle. There is also news from Elon Musk. He wants to examine US gold reserves! This is once again leading to conspiracy theories – this time, the question is whether there is actually gold in Fort Knox. Meanwhile, experts see the gold price marching towards USD 3,500. The rally has now even reached the crisis-stricken Barrick Gold, with the stock climbing after recent announcements. Is all the bad news priced in? The stock of Globex Mining is performing significantly better than Barrick. And at the mine incubator, the price is being driven by positive newsflow. With its risk-diversified commodity portfolio, the stock still has potential.
Read
Commented by Fabian Lorenz on February 19th, 2025 | 07:55 CET
D-Wave makes a big splash! Palantir and the PayPal mafia! AI, quantum computing, and crypto in the Credissential stock!
Quantum computing has arrived in Germany! With the help of D-Wave, the Jülich Research Center plans to advance the research, simulation, and optimization of future technologies such as AI, quantum, and neuromorphic computing. Will this help D-Wave's high-flyer stock to develop new momentum? A real hidden gem (for now) is the Credissential stock. The software company combines AI, quantum computing, and crypto. The breakthrough is expected in 2025 when the stock is expected to take off. And what is Palantir doing? The stock is unstoppable, surpassing corporate growth. Investors are speculating about the PayPal Mafia and government contracts worth billions. And then, of course, there is the direct line to the US Vice President.
Read
Commented by Fabian Lorenz on February 19th, 2025 | 07:25 CET
FOMO Rally in energy and defense! Hensoldt, Siemens Energy, First Hydrogen
Shares in the energy and defense sectors continue to be among the most rapidly rising stocks. First Hydrogen has catch-up potential. The hydrogen specialist is currently expanding its business model and plans to use nuclear power, a potential the market has yet to recognize. Siemens Energy is also profiting from the world's hunger for energy. The latest figures are convincing; the free cash flow is exploding, and even the problem child Gamesa is picking itself up. However, analysts believe the stock might face some headwinds. The Hensoldt share is also unstoppable, riding the FOMO rally in Rheinmetall & Co. The share price surge accelerated again at the start of the week. NATO countries are preparing for years of massive investments. Can this momentum continue?
Read
Commented by Fabian Lorenz on February 14th, 2025 | 07:00 CET
SHARE PRICES are falling at Plug Power, Nel, and Hensoldt! BUY RECOMMENDATION for BMW partner European Lithium!
Buy opportunity or bankruptcy? Shares in Plug Power, Nel, and Hensoldt are under pressure these days. The former hydrogen favorites are facing one piece of bad news after another. After mass layoffs at Nel, the next catastrophe comes from Plug Power. Investors are also getting nervous about Rheinmetall, Renk, and Hensoldt. Is a correction looming? Analysts believe the correction at Hensoldt should be seen as a buying opportunity. At BMW partner European Lithium, analysts even see potential for a multiple increase in value. The stock, which focuses on lithium and rare earths, has gained traction, and the current consolidation offers an exciting entry opportunity. Even peace in Ukraine could benefit these companies.
Read
Commented by Fabian Lorenz on February 13th, 2025 | 07:10 CET
ACQUISITION?! Renk, BioNTech, and Biotech Highflyer Vidac Pharma
Is Renk about to be taken over? Quite possible. The Company, known for its transmissions for the Leopard tank, has a new major shareholder. And it turns out to be none other than KNDS – the maker of the Leopard 2 tank. The Renk share price reacted with a jump of 10%. Is there more to come? Vidac Pharma is also frequently mentioned as a potential takeover candidate. Like BMW, the Company is working on a "new class". But in this case, it is to save human lives. To this end, last year's biotech highflyer aims to revolutionize cancer treatment. Experts believe that a multiplication of the share price is possible. BioNTech is also fighting cancer. In addition to its own research, the German company is strategically focusing on acquisitions. Another one has just been completed. What is next?
Read
Commented by Fabian Lorenz on February 12th, 2025 | 07:00 CET
Analysts on the TUI CRASH! Bayer to make millions! dynaCERT stock is set to skyrocket!
Will the dynaCERT stock see a breakthrough soon? The odds are looking good. In an analyst interview, the top German manager cites an increase in revenue, sales, and earnings as a clear goal for the next 12 months. In that case, the stock would currently be a bargain. The TUI share, however, does not appear to be a bargain for investors. The quarterly figures led to a sell-off yesterday. Yet revenue and earnings were in line with expectations. What do analysts say? Bayer's stock also trended weak yesterday, despite new potential millions in revenue from a drug approval.
Read
Commented by Fabian Lorenz on February 11th, 2025 | 07:10 CET
Buy Puma shares now? Caution advised with Renk, Rheinmetall & Co.! Hidden Gem Nova Pacific Metals launches!
Even if it is not what Donald Trump wants to hear, the US is dependent on imports from Canada, particularly for raw materials. The tariff disputes only highlight this. Accordingly, Canadian raw materials stocks are coming to the attention of investors. One such hidden gem is Nova Pacific Metals, but this could change soon. In contrast, defense stocks could face a strong pullback as Donald Trump increases pressure. Is now the time to take profits at Renk, Rheinmetall, and Co.? Puma shareholders have been waiting for price gains for some time. Is now the time to enter the market after the recent crash?
Read
Commented by Fabian Lorenz on February 10th, 2025 | 07:30 CET
BIOTECH stocks in RALLY MODE: Valneva, BioNxt Solutions, Evotec – BUY signal or correction?
After the 50% rally, the stock of BioNxt Solutions is currently consolidating. However, the next buy signal could be generated soon. There will likely be some exciting announcements this year and perhaps even a strategic partnership. The new R&D site in Munich will likely also attract attention for the innovative biotech company in Germany. After the catastrophic year, things have quieted down for the time being at Evotec. Or is it more that the air has been let out? After all, there is a lot of uncertainty about what skeletons might still be in the closet and how things should continue strategically. The stock market does not like that. In contrast, Valneva has had an impressive rally since mid-January. Last week, there was another big announcement. After 50%, is there more potential with the French company?
Read